Showing 2764 results
-
Press release /
Novartis announces FDA and EMA filing acceptances of Beovu® for patients with diabetic macular edema
Regulatory decisions for Beovu (brolucizumab) in diabetic macular edema (DME) are expected in mid-2022 in the US and Europe DME is the leading cause of blindness in adults in developed… -
Ad hoc release /Annonce événementielle selon l’art. 53 RC Chiffre d’affaires net du T3 en progression de +5% (tcc¹, +6% USD)Innovative Medicines: hausse de +7% (tcc, +8% USD)Forte performance des moteurs de…
-
Ad hoc release /Ad-hoc-Mitteilung gemäss Art. 53 KR Der Nettoumsatz stieg im dritten Quartal um +5% (kWk¹, +6% USD) Die Division Innovative Medicines wuchs um +7% (kWk, +8% USD)Starke Performance der…
-
Pulse Update /
-
Pulse Update /
-
Statement /
-
Story /One man’s fascination with malaria helps fuel the search for new treatments.
-
Story /Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.
-
Story /The disease hobbles families and economies.
-
Story /Suzan Akello describes what life has been like since her cancer diagnosis.